Literature DB >> 10970827

Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray.

T M Hong1, P C Yang, K Peck, J J Chen, S C Yang, Y C Chen, C W Wu.   

Abstract

The phosphatase and tensin homology deleted on chromosome 10 (PTEN) is a tumor suppressor gene with sequence homology to tyrosine phosphatases and the cytoskeletal proteins tensin and auxilin. PTEN has recently been shown to inhibit cell migration and the spreading and formation of focal adhesions. This study investigated the role of PTEN in carcinoma invasion in a lung-cancer cell line and examined the downstream genes regulated by PTEN. We have previously established a cell-line model in human lung adenocarcinoma with different invasive abilities and metastatic potentials. Examining PTEN gene expression in these cell lines, we found that a homozygous deletion in exon 5 is associated with high invasive ability. We then constructed stable constitutive and inducible wild-type PTEN-overexpressed transfectants in the highly invasive cell line CL(1-5). We found that an overexpression of PTEN can inhibit invasion in lung cancer cells. To further explore the downstream genes regulated by PTEN, a high-density complementary DNA (cDNA) microarray technique was used to profile gene changes after PTEN overexpression. Our results indicate a panel of genes that can be modulated by PTEN. PTEN overexpression downregulated genes, including integrin alpha(6), laminin beta(3), heparin-binding epidermal growth factor-like growth factor, urokinase-type plasminogen activator, myb protein B, Akt2, and some expressed sequence tag (EST) clones. In contrast, PTEN overexpression upregulated protein phosphatase 2A1B, ubiquitin protease (unph), secreted phosphoprotein 1, leukocyte elastase inhibitor, nuclear factor-kappaB, cyclic adenosine monophosphate response element binding protein, DNA ligase 1, heat shock protein 90, and some EST genes. Northern hybridization and flow cytometry analysis also confirmed that PTEN overexpression results in the reduced expression of the integrin alpha(6) subunit. The results of this study indicate that PTEN overexpression may inhibit lung cancer invasion by downregulation of a panel of genes including integrin alpha(6). The cDNA microarray technique may be an effective tool to study the downstream function of a tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970827     DOI: 10.1165/ajrcmb.23.3.4002

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

2.  Inhibition of neuronal phenotype by PTEN in PC12 cells.

Authors:  Sergei Musatov; Jill Roberts; Andrew I Brooks; John Pena; Simone Betchen; Donald W Pfaff; Michael G Kaplitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

Review 3.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

4.  PTEN inhibits adrenomedullin expression and function in brain tumor cells.

Authors:  Simone A Betchen; Sergei Musatov; Jill Roberts; John Pena; Michael G Kaplitt
Journal:  J Neurooncol       Date:  2006-07-05       Impact factor: 4.130

5.  Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer.

Authors:  Neil E Martin; Travis Gerke; Jennifer A Sinnott; Edward C Stack; Ove Andrén; Swen-Olof Andersson; Jan-Erik Johansson; Michelangelo Fiorentino; Stephen Finn; Giuseppe Fedele; Meir Stampfer; Philip W Kantoff; Lorelei A Mucci; Massimo Loda
Journal:  Mol Cancer Res       Date:  2015-06-29       Impact factor: 5.852

6.  Dynamic changes of gene expression profiles during postnatal development of the heart in mice.

Authors:  H-W Chen; S-L Yu; W-J Chen; P-C Yang; C-T Chien; H-Y Chou; H-N Li; K Peck; C-H Huang; F-Y Lin; J J W Chen; Y-T Lee
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Characterization of Molecular Markers Indicative of Cervical Cancer Progression.

Authors:  Hilal Arnouk; Mark A Merkley; Robert H Podolsky; Hubert Stöppler; Carlos Santos; Manuel Alvarez; Julio Mariategui; Daron Ferris; Jeffrey R Lee; William S Dynan
Journal:  Proteomics Clin Appl       Date:  2009-05-05       Impact factor: 3.494

8.  PTEN identified as important risk factor of chronic obstructive pulmonary disease.

Authors:  H Dean Hosgood; Idan Menashe; Xingzhou He; Stephen Chanock; Qing Lan
Journal:  Respir Med       Date:  2009-07-21       Impact factor: 3.415

Review 9.  Genome maintenance in the context of 4D chromatin condensation.

Authors:  Sonia Yu; Fan Yang; Wen H Shen
Journal:  Cell Mol Life Sci       Date:  2016-04-20       Impact factor: 9.261

10.  Survival factor NFIL3 restricts FOXO-induced gene expression in cancer.

Authors:  Megan Keniry; Maira M Pires; Sarah Mense; Celine Lefebvre; Boyi Gan; Karen Justiano; Ying-Ka Ingar Lau; Ben Hopkins; Cindy Hodakoski; Susan Koujak; Joseph Toole; Franklyn Fenton; Ashley Calahan; Andrea Califano; Ronald A DePinho; Matt Maurer; Ramon Parsons
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.